Immunogenic cell death in cancer and infectious disease (Q38982422)

8 September 2017

1 reference

title

Immunogenic cell death in cancer and infectious disease (English)

1 reference

8 September 2017

1 reference

1 reference

Laurence Zitvogel

0 references

Guido Kroemer

Guido Kroemer

0 references

Lorenzo Galluzzi

Lorenzo Galluzzi

0 references

Oliver Kepp

Oliver Kepp

0 references

Aitziber Buqué

Aitziber Buqué

0 references

language of work or name

1 reference

17 October 2016

1 reference

Nature Reviews Immunology

8 September 2017

published in

1 reference

8 September 2017

1 reference

8 September 2017

1 reference

8 September 2017

page(s)

97-111

1 reference

Programmed cell death in animal development and disease

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Perception of self: distinguishing autoimmunity from autoinflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Tolerance, danger, and the extended family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

The immune system evolved to discriminate infectious nonself from noninfectious self

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Newly described pattern recognition receptors team up against intracellular pathogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Innate immune recognition of the microbiota promotes host-microbial symbiosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Live to die another way: modes of programmed cell death and the signals emanating from dying cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Neoantigens in cancer immunotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Immunogenic cell death in cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Immunogenic cell death and DAMPs in cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Consensus guidelines for the detection of immunogenic cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Viral control of mitochondrial apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Salmonellae interactions with host processes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Assembly and localization of Toll-like receptor signalling complexes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Central roles of NLRs and inflammasomes in viral infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

STING-dependent cytosolic DNA sensing pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Viral RNA detection by RIG-I-like receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Organelle-Specific Initiation of Autophagy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Endoplasmic reticulum stress in immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Type I interferons in infectious disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Activation and regulation of the inflammasomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Autophagy in malignant transformation and cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

The ins and outs of MHC class II-mediated antigen processing and presentation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Cross-presentation by dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Inducers of immunogenic cancer cell death.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Calreticulin exposure dictates the immunogenicity of cancer cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Human tumor cells killed by anthracyclines induce a tumor-specific immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Immunogenic death of colon cancer cells treated with oxaliplatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

High hydrostatic pressure induces immunogenic cell death in human tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Regulated cell death and adaptive stress responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Trial watch: Dendritic cell-based anticancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Antitumor immunity induced after α irradiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8(+) T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Ultraviolet radiation damages self noncoding RNA and is detected by TLR3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

High hydrostatic pressure treatment generates inactivated mammalian tumor cells with immunogeneic features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Enlightening the impact of immunogenic cell death in photodynamic cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Necroptosis and its role in inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Caspases Connect Cell-Death Signaling to Organismal Homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Mitochondria: master regulators of danger signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Purinergic regulation of the immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

PGE2 induced in and released by dying cells functions as an inhibitory DAMP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Apoptotic cell clearance: basic biology and therapeutic potential.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Murine low-density lipoprotein receptor-related protein 1 (LRP) is required for phagocytosis of targets bearing LRP ligands but is not required for C1q-triggered enhancement of phagocytosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Primary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Capsaicin-mediated apoptosis of human bladder cancer cells activates dendritic cells via CD91.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Expression and significance of CD44, CD47 and c-met in ovarian clear cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

The common heat shock protein receptor CD91 is up-regulated on monocytes of advanced melanoma slow progressors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Type I interferons in anticancer immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

HMGB1 and RAGE in inflammation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

A Mouse Model of Zika Virus Pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Annexin A1 and glucocorticoids as effectors of the resolution of inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Interaction of ICP34.5 with Beclin 1 modulates herpes simplex virus type 1 pathogenesis through control of CD4+ T-cell responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Viral strategies for the evasion of immunogenic cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Viral subversion of immunogenic cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Inflammasome inhibition as a pathogenic stealth mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Coordinated regulation of myeloid cells by tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

T cell receptor signalling in the control of regulatory T cell differentiation and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Hallmarks of Cancer: The Next Generation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Serum levels of calreticulin in correlation with disease activity in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Occurrence of IgA and IgG Autoantibodies to Calreticulin in Coeliac Disease and Various Autoimmune Diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Immunoproteomic to identify antigens in the intestinal mucosa of Crohn's disease patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Cardiac glycosides exert anticancer effects by inducing immunogenic cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Vaccines for established cancer: overcoming the challenges posed by immune evasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.107

Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein

31 March 2020

1 reference

12 December 2020

Strategies for antigen loading of dendritic cells to enhance the antitumor immune response

1 reference

12 December 2020

Combinatorial strategies for the induction of immunogenic cell death

1 reference

12 December 2020

Necroptosis: Mechanisms and Relevance to Disease

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRI.2016.107

1 reference

8 September 2017

1 reference